Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60–64

Abstract

It has been suggested that increased oxidative stress may be both a cause as well as a consequence of hypertension. In vivo oxidation of low-density lipoproteins by oxygen-free radicals may increase hypertension-related atherogenesis, and antioxidants may be beneficial in this regard. Previous findings concerning associations between serum measures of antioxidants and hypertension have however been inconsistent. Plasma levels of β-carotene, Vitamin A, E, uric acid, homocysteine and total antioxidant capacity, as well as two markers of oxidative stress, malondialdehyde (MDA) and protein carbonyls, were measured in morning fasting blood samples provided by 415 Australians aged 60–64 years, selected randomly from the community. Participants also provided information on sociodemographic attributes, mental and physical health, and provided two measures of resting blood pressure, allowing a diagnosis of definite or borderline hypertension. Those with hypertension had lower levels of β-carotene and higher levels of uric acid and MDA compared to normotensive participants. The last two of these associations persisted when the analyses controlled for lifestyle and health factors. The findings from this study offer limited support for the proposition that lower antioxidant status and higher oxidative stress are associated with hypertension, and suggest the need for longitudinal studies to examine causality and intervention studies to determine the benefit of antioxidants in this group.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Griedling KK, Fitzgerald GA . Oxidative stress and cardiovascular injury. Part II. Animal and human studies. Circulation 2003; 108: 2034–2040.

    Article  Google Scholar 

  2. Oparil S, Zaman MA, Calhoun DA . Pathogenesis of hypertension. Ann Int Med 2003; 139: 761–776.

    Article  CAS  Google Scholar 

  3. Kumar KV, Das UN . Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Red Commun 1993; 19: 59–66.

    Article  CAS  Google Scholar 

  4. Beckman KB, Ames BN . The free radical theory of aging matures. Physiol Rev 1998; 78: 547–581.

    Article  CAS  Google Scholar 

  5. Jessup W, Kritharides L, Stocker R . Lipid oxidation in atherogenesis: an overview. Biochem Soc Trans 2004; 32: 134–138.

    Article  CAS  Google Scholar 

  6. Maxwell SR . Can anti-oxidants prevent ischaemic heart disease? J Clin Pharm Ther 1993; 18: 85–95.

    Article  CAS  Google Scholar 

  7. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23–33.

  8. Klipstein-Grobusch K, Geleijnse JM, den Breejen JH . Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1998; 69: 261–266.

    Article  Google Scholar 

  9. Yochum LA, Folsom AR, Kushi LH . Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 2000; 72: 476–483.

    Article  CAS  Google Scholar 

  10. Asplund K . Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med 2002; 251: 372–392.

    Article  CAS  Google Scholar 

  11. Duffy SJ et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048–2049.

    Article  CAS  Google Scholar 

  12. Kim MK et al. Lack of long-term effect of Vitamin C supplementation on blood pressure. Hypertension 2002; 40: 797–803.

    Article  CAS  Google Scholar 

  13. Ness AR, Chee D, Elliott P . Vitamin C and blood pressure — an overview. J Hum Hypertens 1997; 11: 343–350.

    Article  CAS  Google Scholar 

  14. Chen J et al. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 2002; 40: 810–816.

    Article  CAS  Google Scholar 

  15. Ware JE, Kosinski M, Keller SD . A 12-item Short Form Health Survey. Med Care 1996; 34: 220–233.

    Article  Google Scholar 

  16. Catignani GL . Simultaneous determination of retinol and alpha tocopherol in serum and plasma by liquid chromatography. Clin Chem 1983; 29: 708–712.

    CAS  PubMed  Google Scholar 

  17. Pilz J, Meineke I, Gleiter CH . Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenyl-hydrazine derivative. J Chromatogr B Biomed Sci Appl 2000; 9: 315–325.

    Article  Google Scholar 

  18. Roberts PA, Knight J, Campbell AK . Pholasin: a bioluminescent indicator for detecting activation of single neutrophilis. Anal Biochem 1987; 160: 139–148.

    Article  CAS  Google Scholar 

  19. Buss H et al. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med. 1997; 23: 361–366.

    Article  CAS  Google Scholar 

  20. Winterbourn CC, Buss IH . Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 1999; 300: 106–111.

    Article  CAS  Google Scholar 

  21. Fossati P, Prencipe L, Berti G . Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26: 227–231.

    CAS  PubMed  Google Scholar 

  22. Statacorp . Stata Statistical Software: Release 7.0. Stata Corporation: College Station, TX, 2001.

    Google Scholar 

  23. Comstock GW et al. Serum levels of retinol, beta-carotene, and alpha-tocopherol in older adults. Am J Epidemiol 1988; 127: 114–123.

    Article  CAS  Google Scholar 

  24. Goodman DS . Vitamin A and retinoids in health and disease. N Engl J Med 1984; 310: 1023–1031.

    Article  CAS  Google Scholar 

  25. Galley HF et al. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci 1997; 92: 361–365.

    Article  CAS  Google Scholar 

  26. Miller ER, Appel LJ, Levander OA, Levine DM . The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk 1997; 4: 19–24.

    Article  Google Scholar 

  27. Russo C et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267–1271.

    Article  CAS  Google Scholar 

  28. Palumbo G et al. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens 2000; 13: 564–567.

    Article  CAS  Google Scholar 

  29. Rossell M, Regnstrom J, Kallner A, Hellenuis M-L . Serum urate determines antioxidant capacity in middle-aged men—a controlled, randomized diet and exercise intervention study. J Int Med 1999; 246: 219–226.

    Article  Google Scholar 

  30. Simie MG, Jovanovic SV . Antioxidation mechanisms of uric acid. J Am Chem Soc 1989; 111: 5778–5782.

    Article  Google Scholar 

  31. Wayner DDM et al. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochem Biophys Acta 1987; 924: 408–419.

    Article  CAS  Google Scholar 

  32. Johnson RJ et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183–1190.

    Article  CAS  Google Scholar 

  33. Mazzali M et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101–1106.

    Article  CAS  Google Scholar 

  34. Wen Y, Killalea S, McGettigan P, Feely J . Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Ir J Med Sci 1996; 165: 210–212.

    Article  CAS  Google Scholar 

  35. Janero DR . Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515–540.

    Article  CAS  Google Scholar 

  36. Cuccurollo F et al. Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension. J Mol Cell Cardiol 1991; 23: 727–734.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Helen Christensen, Bryan Rodgers, Karen Maxwell, Trish Jacomb and the team of interviewers from the Centre for Mental Health Research for their assistance with this study. We also thank Paul Stathakis, Department of Clinical Chemistry, for his technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R A Parslow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parslow, R., Sachdev, P., Salonikas, C. et al. Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60–64. J Hum Hypertens 19, 219–226 (2005). https://doi.org/10.1038/sj.jhh.1001809

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001809

Keywords

This article is cited by

Search

Quick links